{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:44:00Z","timestamp":1788558240113,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013041","name":"vice-chancellor for research, shiraz university of medical sciences","doi-asserted-by":"publisher","award":["99-01-05-23159"],"award-info":[{"award-number":["99-01-05-23159"]}],"id":[{"id":"10.13039\/501100013041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Pept Res Ther"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s10989-021-10284-y","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T13:04:03Z","timestamp":1631797443000},"page":"2703-2716","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Viral 3CLpro as a Target for Antiviral Intervention Using Milk-Derived Bioactive Peptides"],"prefix":"10.1007","volume":"27","author":[{"given":"Yasaman","family":"Behzadipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Gholampour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Pirhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Seradj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Khoshneviszadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-9569","authenticated-orcid":false,"given":"Shiva","family":"Hemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"10284_CR1","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1128\/JVI.77.15.8181-8186.2003","volume":"77","author":"P Ahlquist","year":"2003","unstructured":"Ahlquist P, Noueiry AO, Lee W-M, Kushner DB, Dye BT (2003) Host factors in positive-strand RNA virus genome replication. J Virol 77:8181\u20138186. https:\/\/doi.org\/10.1128\/JVI.77.15.8181-8186.2003","journal-title":"J Virol"},{"key":"10284_CR2","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1126\/science.1085658","volume":"300","author":"K Anand","year":"2003","unstructured":"Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R (2003) Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300:1763\u20131767. https:\/\/doi.org\/10.1126\/science.1085658","journal-title":"Science"},{"key":"10284_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-540-79086-0_4","volume-title":"Antiviral strategies","author":"J Anderson","year":"2009","unstructured":"Anderson J, Schiffer C, Lee S-K, Swanstrom R (2009) Viral protease inhibitors. In: Kr\u00e4usslich H-G, Bartenschlager R (eds) Antiviral strategies. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 85\u2013110"},{"key":"10284_CR4","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/molecules26020430","volume":"26","author":"V Apostolopoulos","year":"2021","unstructured":"Apostolopoulos V, Bojarska J, Chai T-T, Elnagdy S, Kaczmarek K, Matsoukas J, New R, Parang K, Lopez OP, Parhiz H, Perera CO, Pickholz M, Remko M, Saviano M, Skwarczynski M, Tang Y, Wolf WM, Yoshiya T, Zabrocki J, Zielenkiewicz P, AlKhazindar M, Barriga V, Kelaidonis K, Sarasia EM, Toth I (2021) A global review on short peptides: frontiers and perspectives. Molecules 26:430","journal-title":"Molecules"},{"key":"10284_CR5","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.3390\/molecules24234318","volume":"24","author":"Y Behzadipour","year":"2019","unstructured":"Behzadipour Y, Hemmati S (2019) Considerations on the rational design of covalently conjugated cell-penetrating peptides (CPPs) for Intracellular delivery of proteins: a guide to CPP selection using glucarpidase as the model cargo molecule. Molecules 24:4318. https:\/\/doi.org\/10.3390\/molecules24234318","journal-title":"Molecules"},{"key":"10284_CR6","doi-asserted-by":"publisher","first-page":"118080","DOI":"10.1016\/j.lfs.2020.118080","volume":"257","author":"S Bharadwaj","year":"2020","unstructured":"Bharadwaj S, Lee KE, Dwivedi VD, Kang SG (2020) Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations. Life Sci 257:118080","journal-title":"Life Sci"},{"key":"10284_CR7","doi-asserted-by":"publisher","first-page":"173781","DOI":"10.1016\/j.ejphar.2020.173781","volume":"891","author":"B \u00c7ak\u0131r","year":"2021","unstructured":"\u00c7ak\u0131r B, Okuyan B, \u015eener G, Tunali-Akbay T (2021) Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): in silico analysis. Eur J Pharmacol 891:173781. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173781","journal-title":"Eur J Pharmacol"},{"key":"10284_CR8","doi-asserted-by":"publisher","first-page":"22843","DOI":"10.1038\/srep22843","volume":"6","author":"K Chaudhary","year":"2016","unstructured":"Chaudhary K, Kumar R, Singh S, Tuknait A, Gautam A, Mathur D, Anand P, Varshney GC, Raghava GPS (2016) A web server and mobile app for computing hemolytic potency of peptides. Sci Rep 6:22843. https:\/\/doi.org\/10.1038\/srep22843","journal-title":"Sci Rep"},{"key":"10284_CR9","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1021\/ci200317s","volume":"51","author":"F Cheng","year":"2011","unstructured":"Cheng F, Yu Y, Zhou Y, Shen Z, Xiao W, Liu G, Li W, Lee PW, Tang Y (2011) Insights into molecular basis of cytochrome P450 inhibitory promiscuity of compounds. J Chem Inf Model 51:2482\u20132495. https:\/\/doi.org\/10.1021\/ci200317s","journal-title":"J Chem Inf Model"},{"key":"10284_CR10","doi-asserted-by":"publisher","first-page":"601753","DOI":"10.3389\/fmolb.2020.601753","volume":"7","author":"R Chourasia","year":"2020","unstructured":"Chourasia R, Padhi S, Chiring Phukon L, Abedin MM, Singh SP, Rai AK (2020) A potential peptide from soy cheese produced using Lactobacillus delbrueckii WS4 for effective inhibition of SARS-CoV-2 main protease and S1 glycoprotein. Front Mol Biosci 7:601753. https:\/\/doi.org\/10.3389\/fmolb.2020.601753","journal-title":"Front Mol Biosci"},{"key":"10284_CR11","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1126\/science.abb4489","volume":"368","author":"W Dai","year":"2020","unstructured":"Dai W, Zhang B, Jiang X-M, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang L-K, Xu Y, Yang H, Liu H (2020) Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science 368:1331. https:\/\/doi.org\/10.1126\/science.abb4489","journal-title":"Science"},{"key":"10284_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1208\/s12248-014-9687-3","volume":"17","author":"L Di","year":"2015","unstructured":"Di L (2015) Strategic approaches to optimizing peptide ADME properties. AAPS J 17:134\u2013143. https:\/\/doi.org\/10.1208\/s12248-014-9687-3","journal-title":"AAPS J"},{"key":"10284_CR13","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/bioinformatics\/btt619","volume":"30","author":"I Dimitrov","year":"2013","unstructured":"Dimitrov I, Naneva L, Doytchinova I, Bangov I (2013) AllergenFP: allergenicity prediction by descriptor fingerprints. Bioinformatics 30:846\u2013851. https:\/\/doi.org\/10.1093\/bioinformatics\/btt619","journal-title":"Bioinformatics"},{"key":"10284_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/md18040225","volume":"18","author":"D Gentile","year":"2020","unstructured":"Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A (2020) Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study. Mar Drugs 18:225. https:\/\/doi.org\/10.3390\/md18040225","journal-title":"Mar Drugs"},{"key":"10284_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41577-021-00556-5","volume":"21","author":"RK Gupta","year":"2021","unstructured":"Gupta RK (2021) Will SARS-CoV-2 variants of concern affect the promise of vaccines? Nat Rev Immunol 21:340\u2013341. https:\/\/doi.org\/10.1038\/s41577-021-00556-5","journal-title":"Nat Rev Immunol"},{"key":"10284_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117831","author":"AB Gurung","year":"2020","unstructured":"Gurung AB, Ali MA, Lee J, Farah MA, Al-Anazi KM (2020) Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2020.117831","journal-title":"Life Sci"},{"key":"10284_CR17","doi-asserted-by":"publisher","first-page":"104474","DOI":"10.1016\/j.meegid.2020.104474","volume":"85","author":"S Hemmati","year":"2020","unstructured":"Hemmati S, Behzadipour Y, Haddad M (2020) Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors. Infect Genet Evol 85:104474. https:\/\/doi.org\/10.1016\/j.meegid.2020.104474","journal-title":"Infect Genet Evol"},{"key":"10284_CR18","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1111\/febs.12936","volume":"281","author":"R Hilgenfeld","year":"2014","unstructured":"Hilgenfeld R (2014) From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 281:4085\u20134096. https:\/\/doi.org\/10.1111\/febs.12936","journal-title":"FEBS J"},{"key":"10284_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, Yang X, Bai F, Liu H, Liu X, Guddat LW, Xu W, Xiao G, Qin C, Shi Z, Jiang H, Rao Z, Yang H (2020) Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature 582:289\u2013293. https:\/\/doi.org\/10.1038\/s41586-020-2223-y","journal-title":"Nature"},{"key":"10284_CR20","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3390\/molecules26103003","volume":"26","author":"M Juki\u010d","year":"2021","unstructured":"Juki\u010d M, \u0160krlj B, Tom\u0161i\u010d G, Ple\u0161ko S, Podlipnik \u010c, Bren U (2021) Prioritisation of compounds for 3CLpro inhibitor development on SARS-CoV-2 variants. Molecules 26:3003. https:\/\/doi.org\/10.3390\/molecules26103003","journal-title":"Molecules"},{"key":"10284_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13054-021-03662-x","volume":"25","author":"J Khateeb","year":"2021","unstructured":"Khateeb J, Li Y, Zhang H (2021) Emerging SARS-CoV-2 variants of concern and potential intervention approaches. Crit Care 25:244. https:\/\/doi.org\/10.1186\/s13054-021-03662-x","journal-title":"Crit Care"},{"key":"10284_CR22","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.1128\/jvi.01348-12","volume":"86","author":"Y Kim","year":"2012","unstructured":"Kim Y, Lovell S, Tiew K-C, Mandadapu SR, Alliston KR, Battaile KP, Groutas WC, Chang K-O (2012) Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses. J Virol 86:11754\u201311762. https:\/\/doi.org\/10.1128\/jvi.01348-12","journal-title":"J Virol"},{"key":"10284_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jff.2009.01.007","volume":"1","author":"H Korhonen","year":"2009","unstructured":"Korhonen H (2009) Milk-derived bioactive peptides: from science to applications. J Funct Foods 1:177\u2013187. https:\/\/doi.org\/10.1016\/j.jff.2009.01.007","journal-title":"J Funct Foods"},{"key":"10284_CR24","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari R, Kumar R, Consortium OSDD, Lynn A (2014) g_mmpbsa\u2014A GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model 54:1951\u20131962. https:\/\/doi.org\/10.1021\/ci500020m","journal-title":"J Chem Inf Model"},{"key":"10284_CR25","doi-asserted-by":"publisher","first-page":"6672","DOI":"10.1021\/jm0605233","volume":"49","author":"AG Leach","year":"2006","unstructured":"Leach AG, Jones HD, Cosgrove DA, Kenny PW, Ruston L, MacFaul P, Wood JM, Colclough N, Law B (2006) Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. J Med Chem 49:6672\u20136682. https:\/\/doi.org\/10.1021\/jm0605233","journal-title":"J Med Chem"},{"key":"10284_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235\u2013249. https:\/\/doi.org\/10.1016\/s1056-8719(00)00107-6","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10284_CR27","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1248\/cpb.48.1310","volume":"48","author":"T Mimoto","year":"2000","unstructured":"Mimoto T, Hattori N, Takaku H, Kisanuki S, Fukazawa T, Terashima K, Kato R, Nojima S, Misawa S, Ueno T (2000) Structure-activity relationship of orally potent tripeptide-based HIV protease inhibitors containing hydroxymethylcarbonyl isostere. Chem Pharm Bull 48:1310\u20131326. https:\/\/doi.org\/10.1248\/cpb.48.1310","journal-title":"Chem Pharm Bull"},{"key":"10284_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.sjbs.2015.06.005","volume":"23","author":"DP Mohanty","year":"2016","unstructured":"Mohanty DP, Mohapatra S, Misra S, Sahu PS (2016) Milk derived bioactive peptides and their impact on human health \u2013 a review. Saudi J Biol Sci 23:577\u2013583. https:\/\/doi.org\/10.1016\/j.sjbs.2015.06.005","journal-title":"Saudi J Biol Sci"},{"key":"10284_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.micinf.2020.04.009","volume":"22","author":"MA Moreno-Eutimio","year":"2020","unstructured":"Moreno-Eutimio MA, L\u00f3pez-Mac\u00edas C, Pastelin-Palacios R (2020) Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7\/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes. Microb Infect 22:226\u2013229. https:\/\/doi.org\/10.1016\/j.micinf.2020.04.009","journal-title":"Microb Infect"},{"key":"10284_CR30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.idairyj.2006.06.010","volume":"16","author":"Y Pan","year":"2006","unstructured":"Pan Y, Lee A, Wan J, Coventry MJ, Michalski WP, Shiell B, Roginski H (2006) Antiviral properties of milk proteins and peptides. Int Dairy J 16:1252\u20131261. https:\/\/doi.org\/10.1016\/j.idairyj.2006.06.010","journal-title":"Int Dairy J"},{"key":"10284_CR31","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jmv.25915","volume":"92","author":"A Paniz-Mondolfi","year":"2020","unstructured":"Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M (2020) Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 92:699\u2013702. https:\/\/doi.org\/10.1002\/jmv.25915","journal-title":"J Med Virol"},{"key":"10284_CR32","doi-asserted-by":"publisher","first-page":"e02076","DOI":"10.1016\/j.heliyon.2019.e02076","volume":"5","author":"T Panyayai","year":"2019","unstructured":"Panyayai T, Ngamphiw C, Tongsima S, Mhuantong W, Limsripraphan W, Choowongkomon K, Sawatdichaikul O (2019) FeptideDB: a web application for new bioactive peptides from food protein. Heliyon 5:e02076. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e02076","journal-title":"Heliyon"},{"key":"10284_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.drudis.2020.01.015","volume":"25","author":"T Pillaiyar","year":"2020","unstructured":"Pillaiyar T, Meenakshisundaram S, Manickam M (2020) Recent discovery and development of inhibitors targeting coronaviruses. Drug Discov Today 25:668\u2013688. https:\/\/doi.org\/10.1016\/j.drudis.2020.01.015","journal-title":"Drug Discov Today"},{"key":"10284_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/10799893.2020.1735418","volume":"40","author":"S Pirhadi","year":"2020","unstructured":"Pirhadi S, Damghani T, Avestan MS, Sharifi S (2020) Dual potent c-Met and ALK inhibitors: from common feature pharmacophore modeling to structure based virtual screening. J Recept Signal Transduct Res 40:357\u2013364. https:\/\/doi.org\/10.1080\/10799893.2020.1735418","journal-title":"J Recept Signal Transduct Res"},{"key":"10284_CR35","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J, Prot M, Gallais F, Gantner P, Velay A, Le Guen J, Kassis-Chikhani N, Edriss D, Belec L, Seve A, Courtellemont L, P\u00e9r\u00e9 H, Hocqueloux L, Fafi-Kremer S, Prazuck T, Mouquet H, Bruel T, Simon-Lori\u00e8re E, Rey FA, Schwartz O (2021) Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596:276\u2013280. https:\/\/doi.org\/10.1038\/s41586-021-03777-9","journal-title":"Nature"},{"key":"10284_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s10930-021-09983-8","volume":"40","author":"H Pradeep","year":"2021","unstructured":"Pradeep H, Najma U, Aparna HS (2021) Milk peptides as novel multi-targeted therapeutic candidates for SARS-CoV2. Protein J 40:310\u2013327. https:\/\/doi.org\/10.1007\/s10930-021-09983-8","journal-title":"Protein J"},{"key":"10284_CR37","doi-asserted-by":"publisher","DOI":"10.2174\/97816080549611130201","volume-title":"Advances in anticancer agents in medicinal chemistry","author":"M Prudhomme","year":"2013","unstructured":"Prudhomme M (2013) Advances in anticancer agents in medicinal chemistry. Bentham Science Publishers, Sharjah"},{"key":"10284_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.enzmictec.2018.12.006","volume":"122","author":"SS Rahmatabadi","year":"2019","unstructured":"Rahmatabadi SS, Sadeghian I, Ghasemi Y, Sakhteman A, Hemmati S (2019) Identification and characterization of a sterically robust phenylalanine ammonia-lyase among 481 natural isoforms through association of in silico and in vitro studies. Enzyme Microb Technol 122:36\u201354. https:\/\/doi.org\/10.1016\/j.enzmictec.2018.12.006","journal-title":"Enzyme Microb Technol"},{"key":"10284_CR39","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.bmcl.2008.02.053","volume":"18","author":"JT Randolph","year":"2008","unstructured":"Randolph JT, Zhang X, Huang PP, Klein LL, Kurtz KA, Konstantinidis AK, He W, Kati WM, Kempf DJ (2008) Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor. Biorganic Med Chem Lett 18:2745\u20132750. https:\/\/doi.org\/10.1016\/j.bmcl.2008.02.053","journal-title":"Biorganic Med Chem Lett"},{"key":"10284_CR40","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1080\/00498250701875254","volume":"38","author":"I Rubio-Aliaga","year":"2008","unstructured":"Rubio-Aliaga I, Daniel H (2008) Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38:1022\u20131042. https:\/\/doi.org\/10.1080\/00498250701875254","journal-title":"Xenobiotica"},{"key":"10284_CR41","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/bip.22067","volume":"98","author":"S Santos","year":"2012","unstructured":"Santos S, Torcato I, Castanho MA (2012) Biomedical applications of dipeptides and tripeptides. Pept Sci 98:288\u2013293. https:\/\/doi.org\/10.1002\/bip.22067","journal-title":"Pept Sci"},{"key":"10284_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.antiviral.2011.07.002","volume":"92","author":"A Sch\u00fcller","year":"2011","unstructured":"Sch\u00fcller A, Yin Z, Brian Chia CS, Doan DNP, Kim H-K, Shang L, Loh TP, Hill J, Vasudevan SG (2011) Tripeptide inhibitors of dengue and West Nile virus NS2B\u2013NS3 protease. Antiviral Res 92:96\u2013101. https:\/\/doi.org\/10.1016\/j.antiviral.2011.07.002","journal-title":"Antiviral Res"},{"key":"10284_CR43","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1208\/s12248-014-9599-2","volume":"16","author":"G Shankar","year":"2014","unstructured":"Shankar G, Arkin S, Cocea L, Devanarayan V, Kirshner S, Kromminga A, Quarmby V, Richards S, Schneider CK, Subramanyam M, Swanson S, Verthelyi D, Yim S (2014) Assessment and reporting of the clinical immunogenicity of therapeutic proteins and peptides-harmonized terminology and tactical recommendations. AAPS J 16:658\u2013673. https:\/\/doi.org\/10.1208\/s12248-014-9599-2","journal-title":"AAPS J"},{"key":"10284_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10989-020-10063-1","volume":"27","author":"P Sharma","year":"2021","unstructured":"Sharma P, Kaur H, Kehinde BA, Chhikara N, Sharma D, Panghal A (2021) Food-derived anticancer peptides: a review. Int J Pept Res Ther 27:55\u201370. https:\/\/doi.org\/10.1007\/s10989-020-10063-1","journal-title":"Int J Pept Res Ther"},{"key":"10284_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4155\/fmc-2016-0188","volume":"9","author":"TS Win","year":"2017","unstructured":"Win TS, Malik AA, Prachayasittikul V, Wikberg S, Nantasenamat JE, Shoombuatong C (2017) HemoPred: a web server for predicting the hemolytic activity of peptides. Future Med Chem 9:275\u2013291. https:\/\/doi.org\/10.4155\/fmc-2016-0188","journal-title":"Future Med Chem"},{"key":"10284_CR46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.tifs.2019.02.050","volume":"86","author":"Q Xu","year":"2019","unstructured":"Xu Q, Hong H, Wu J, Yan X (2019a) Bioavailability of bioactive peptides derived from food proteins across the intestinal epithelial membrane: a review. Trends Food Sci Technol 86:399\u2013411. https:\/\/doi.org\/10.1016\/j.tifs.2019.02.050","journal-title":"Trends Food Sci Technol"},{"key":"10284_CR47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1111\/ijfs.14055","volume":"54","author":"Q Xu","year":"2019","unstructured":"Xu Q, Yan X, Zhang Y, Wu J (2019b) Current understanding of transport and bioavailability of bioactive peptides derived from dairy proteins: a review. Int J Food Sci Technol 54:1930\u20131941. https:\/\/doi.org\/10.1111\/ijfs.14055","journal-title":"Int J Food Sci Technol"},{"key":"10284_CR48","doi-asserted-by":"publisher","first-page":"13190","DOI":"10.1073\/pnas.1835675100","volume":"100","author":"H Yang","year":"2003","unstructured":"Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z (2003) The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A 100:13190\u201313195. https:\/\/doi.org\/10.1073\/pnas.1835675100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10284_CR49","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/bioinformatics\/bty707","volume":"35","author":"H Yang","year":"2019","unstructured":"Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, Li W, Liu G, Tang Y (2019) admetSAR 2.0: web-service for prediction and optimization of chemical ADMET properties. Bioinformatics 35:1067\u20131069. https:\/\/doi.org\/10.1093\/bioinformatics\/bty707","journal-title":"Bioinformatics"},{"key":"10284_CR50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R (2020) Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science 368:409\u2013412. https:\/\/doi.org\/10.1126\/science.abb3405","journal-title":"Science"}],"container-title":["International Journal of Peptide Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-021-10284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10989-021-10284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10989-021-10284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:36:00Z","timestamp":1744191360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10989-021-10284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10284"],"URL":"https:\/\/doi.org\/10.1007\/s10989-021-10284-y","relation":{},"ISSN":["1573-3149","1573-3904"],"issn-type":[{"value":"1573-3149","type":"print"},{"value":"1573-3904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"8 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"IR.SUMS.REC.1399.569.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}